Apr 28, 2025, 12:19

DKMS John Hansen Research Grant

The DKMS John Hansen Research Grant provides €240,000 over three years to support young researchers working on hematopoietic stem cell transplantation and cell therapy for hematological diseases. The grant is administered by DKMS Group gGmbH and honors the contributions of John A. Hansen.

Eligibility Criteria

PhD, MD, or equivalent obtained within the last 10 years
Open to Fellows, Postdoctoral Fellows, and Junior Faculty
Applicants from all countries are eligible
No requirement to hold a faculty position
Research must focus on stem cell transplantation or cell therapy for hematological diseases

Funding Details

€240,000 total over 3 years (€80,000 per year maximum)
Up to 4 projects selected
Funding contingent on reasonable progress

Key Deadlines

Next call for applications to be announced in 2025

Where to Go for Further Information

Visit DKMS Grant Page
Contact: [email protected]

blood cancers Cancer research Cell Therapy DKMS DKMS John Hansen Research Grant DKMS Stiftung Leben Spenden early-career cancer research grants for young investigators hematological diseases hematopoietic stem cell transplantation immunotherapy John A. Hansen OncoDaily Oncology Stem Cell Research

Agenus Bets Big on Botensilimab

Carlos Rodriguez-Galindo: Childhood cancer has long been overlooked in global strategies - It is time to change that

EMBER-3 Trial Updates from ESMO Breast 2025: Imlunestrant Plus Abemaciclib Improves PFS in CDK4/6i-Pretreated ER+/HER2- Breast Cancer

FDA Grants Accelerated Approval for Telisotuzumab Vedotin (EMRELIS™) in c-MET–Overexpressing Advanced Non-Small Cell Lung Cancer

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research